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ABSTRACT 
Introduction:  Glioma is a primary brain tumor derived from neuralgia cells like astrocytes, oligodendrocytes 
and ependymal cells. It is a non curable malignant tumor. Therefore, the objective of the treatment is mainly to 
improve quality of life. 
Objective:  To determine the effectiveness of open surgery for supra-tentorial glioma in terms of improvement in 
Karnofsky performance score. 
Materials and Method:  This Descriptive case series study was conducted at Neurosurgery Department PGMI / 
LRH Peshawar from January 2012 to December 2012 (1 year). Total 144 consecutive patients with supra-
tentorial glioma of more than 18 years of age who underwent open surgery (craniotomy with tumor resection) 
were included. Pre and postoperative Karnofsky performance score was recorded. 
Results:  Total of 144 patients were included in the study, of which 101 were males and 43 females. Age ranged 
from 19 years to 65 years with 36.8% of the patients in the 3
rd
 decade of life. Majority of the patients had supra-
tentorial glioma in the frontal lobe making 38.9% of the whole. In 63.9% of the patients, the procedure was 
effective. It was more effective in young individuals as compared to patients of middle and old age. Furthermore, 
the success rate was more in patients with frontal lobe tumor followed by those with parietal glioma. 
Conclusion:  Open surgery with total or partial resection of tumor is an effective procedure for the treatment of 
supra-tentorial glioma. Its effectiveness is influenced by the age of patient, location of the tumor and preoperative 
Karnofsky performance score. 
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INTRODUCTION 
Primary malignant brain tumors account for approxi-
mately 2% of all cancers in US adults. Glioma is a pri-
mary brain tumor derived from neuroglial cells like as-
trocytes, oligodendrocytes and ependymal cells. It acc-
ounts for more than 80% of primary brain tumors.
1
 
Peak incidence occurs between 35 and 44 years with 
increased prevalence among white people and men.
2
 
 Gliomas are divided into 4 grades. Grade 1 and 2 
are low grade, where as grade 3 and 4 tumors are high 
grade based on cellular origin and histological appea-
rance.
1
 High grade gliomas are generally aggressive 
tumors with poor prognosis. They tend to recur locally 
and rarely spread beyond the confines of central ner-
vous system. Therefore, local control is considered the 
primary determinant of overall survival.
3
 
 Glioma is a common problem that we encounter in 
our population. It is a non curable malignant tumor. 
Therefore, the objective of the treatment is mainly to 
improve quality of life. Several prognostic factors 
have been identified in patients with malignant glioma 
including age, performance status, location of tumor, 
histological grade and extent of resection. Performance 
status rather than histological grade is the key pro-
gnostic factor in elderly patients with supratentorial 
malignant glioma. Therefore, elderly patients with a
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good preoperative Karnofsky perfor-
mance score can be treated aggressively 




 Chemotherapy as the only adjuvant 
therapy has not been advocated for the 




mide, a novel alkylating agent, has sho-
wn modest activity against recurrent 
glioma
 
but the two years over all survi-
val estimate for Glioblastoma multi-




MATERIAL AND METHODS 
This Descriptive case series study was 
conducted in neurosurgery department, 
Lady Reading Hospital, Peshawar from 
January 2012 to December 2012 (1 
year). All patients with supratentorial 
glioma of any grade with age > than 18 
years and baseline karnofsky score of 
20 and above were included in the stu-
dy. Those patients with recurrent glio-
ma, brain stem and optic nerve glioma, 
Gliomas extending to the infratentorial 
region and those crossing the midline, 
Intra-ventricular glioma and patients 
with serious co morbidities (heart and 
chest diseases) affecting Karnofsky 
performance score were excluded from 
the study. 
 After taking approval from the hos-
pital ethical committee, Consent was 
taken from the patients or their relati-
ves. All patients were subjected to de-
tailed history followed by complete 
physical and neurological examinations 
and routine set of investigations. The 
enrolled patients were put on the OT 
list after 4 – 5 days, ensuring blood arr-
angement and anaesthesia assessment 
through an expert anaesthesiologist. On 
the OT day, open surgery (craniotomy 
with partial or gross total resection of 
tumor) was performed under general 
anaesthesia by expert neurosurgeons. 
Table 1:  Gender Distribution. 
 





Male 101 70.1 70.1 70.1 
Female   43 29.9 29.9 100 
Total 144 100 100 100 
 
Table 2:  Age Distribution. 
 






19, 20 9 6.3 6.3 6.3 
21 – 30 53 36.8 36.8 43.1 
31 – 40 19 13.2 13.2 56.3 
41 – 50 24 16.7 16.7 72.9 
51 – 60 34 23.6 23.6 96.5 
> 60 5 3.5 3.5 100.0 
Total 144 100.0 100.0  
 
Table 3:  Disease Distribution. 
 






Frontal 56 38.9 38.9 38.9 
Parietal 20 13.9 13.9 52.8 
Temporal 10 6.9 6.9 59.7 
Occipital 13 9.0 9.0 68.8 
Fronto-parietal 5 3.5 3.5 72.2 
Temporo-parietal 25 17.4 17.4 89.6 
Parieto-occipital 15 10.4 10.4 100.0 
Total 144 100.0 100.0  
 
 All the patients were followed up to 2 weeks post 
operatively for the determination of effectiveness in 
terms of improvement in Karnofsky performance score 
of at least 20. All the above mentioned information in-
cluding name, age, gender and address were recorded 
in a predesigned proforma. The data was entered,
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stored and analyzed in SPSS 
version 10. Mean ± SD was 
calculated for quantitative vari-
ables like age, preoperative and 
postoperative Karnofsky per-
formance score. Frequencies 
and percentages were calcula-
ted for categorical variables 
like gender and effectiveness. 
 
RESULTS 
Gender of Patients 
out of 144 patients, there were 
101 (70.1%) males and 43 
(29.9%) female patients with 
male to female ratio of 2.35:1 
(Table 1). 
 
Age of patients 
The age of patients ranged fr-
om 19 to 65 years. The mean 
age was 39.47 years ± 14.509 





fsky performance status, 101 
(70.1%) patients were having 
score of less than 70 while 43 
(29.9%) patients had KF score 
of 70 and above. 
 
Disease Distribution 
In majority of the patients, the 
space occupying lesion was in 
the frontal lobe i.e. in 56 
(38.9%) followed by patients 
with temporoparietal gliomas 
25 (17.4%). The rest of disease 
distribution is given in Table 3. 
Table 4:  Age Relationship with Outcome. 
 
  Improved Not Improved 
Age Groups Frequencies Number Percentage Number Percentage 
19 – 20 9 0 0 9 100 
21 – 30 53 39 73.6 14 26.4 
31 – 40 19 9 47.4 10 52.6 
41 – 50 24 19 73.6 5 26.4 
51 – 60 34 25 73.5 9 26.5 
> than 60 5 0 0 5 100 
Total 144 72 63.9 52 44.1 
 
Table 5:  Relationship of Location and Outcome. 
 
  Improved Not Improved 
Location Frequencies Number Percentage Number Percentage 
Frontal 56 48 85.7 7 133 
Parietal 20 15 75 5 25 
Occipital 13 9 69.2 4 30.8 
Temporoparietal 25 15 60 10 40 
Retro-occipital 15 5 33.3 10 66.7 
Temporal 10 0 0 10 100 
Total 139*   46  
 
*Few cases involving multiple areas 
 
Table 6:  Karnofsky by Score and Outcome. 
 
  Improved Not Improved 
KF Score Frequency Number Percentage Number Percentage 
More than 70 101 73 72.3 28 21.7 
Less than 70 43 19 44.2 24 45.8 
Total 144 92  52  
 
 
Effectiveness of the Procedure 
Out of 144 patients included in the study the overall 
effectiveness of the procedure was observed in 63.9% 
(92/144) patients as shown in Table 4. 
 The procedure was most effective in patients with 
age range of 41 – 50 years 79.2% (19/24), followed by 
21 – 30 years 73.6% (39/53), 51 – 60 years 73.5% 
(25/34) and 31 – 40 years 47.4% (9/19). The procedure 
was not effective in patients with age 19 – 20 years 
(0/9) and those above 60 years (0/5). 
 In total 101 male patients, the procedure was 
effective in 58 (57.4%) patients while in female the 
effectiveness was 79.07% (34/43). 
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 Frontal lobe gliomas gave the best result 85.7% 
(48/56) followed by parietal lobe tumors 75.0% 
(15/20), occipital lesions 69.2% (9/13) temporoparietal 
gliomas 60.0% (15/25) and parietooccipital tumors 
33.3% (5/15). The procedure was not effective in pati-
ents having temporal gliomas (0/10) (Table 5). 
 Surgery was effective in 72. 3 % (73/101) patients 
with KF score more than 70 and 44.2% (19/43) having 
KF score 70 or less (Table 6). 
 
DISCUSSION 
Complete cure of glioma has always been a dilemma 
and is considered to be a death sentence in neurosur-
gery. Open surgery with partial or total resection of the 
tumor prolongs life expectancy and improves the qua-
lity of life. 
 In our study, most of the patients were young or of 
middle age that is below the age of 61 years making 
96.5% of the whole and male to female ratio was 




 Different opinions exist about the effectiveness of 
open surgery. Some authors consider improvement in 
survival rate as criteria for effectiveness while others 
consider increase in progression free survival as crite-
ria for success. In our study, improvement in Karnof-
sky performance score has been taken as scale for effe-
ctiveness of craniotomy with tumor resection. 
 A range of studies has demonstrated variable suc-




 for glioma surgery in 
terms of improvement in Karnofsky performance sco-
re. In our study, the overall effectiveness is 63.9% 
which is comparable to the most international studies. 
Yoshikawa K
8
 et al showed 38.9% and Tugcu B
9
 et al 
gave 42% effectiveness. Their results are very close to 
each other and are slightly lower than our results. This 
is because, in study performed by Yoshikawa et al, the 
sample size was small (18 patients) and there was no 
significant difference in age of the patients, tumor lo-
cation and preoperative Karnofsky performance score 
while in series of Tugcu B et al, again the number of 
patients was lesser (50) than our study and most of the 
patients were elderly with age more than 70 years. 
This was probably the reason for comparatively lower 
success rate in their series. 
 In another study, Masanori Kurimoto
5
 et al gave 
33.3% overall effectiveness which is much lower than 
our series. His study included 30 patients with the age 
range of 70 to 81 years (median 73.0 years) while in 
our study, maximum age of the patients was 65 years. 
Thus advanced age became the possible reason for 
decreased effectiveness of the procedure. 
 In our study, most of the patients (70%) were hav-
ing poor preoperative functional status with Karnofsky 
performance score of less than 70 but overall effecti-
veness was better than those of studies performed by 
Masanori K and Tugcu B et al. The reason was that 
majority of patients in our study were young with the 
age of 81 (56.3%) patients below 41 years that tolera-
ted surgery in a relatively better way with fewer per-op 
and post-op complications. In most of the patients, 
maximal cytoreduction was achieved by gross total re-
section which added the benefit of comparatively hig-
her success rate. 
 In study performed by XIE Jian
7
 and colleagues, 
the overall success rate was 73.07% which is slightly 
higher than our study. Some of the aspects of their stu-
dy were similar to our series like all of the patients in-
cluded in their study were young and of middle age 
with the age range from 22 – 56 years, majority of 
patients were having frontal lobe tumors followed by 
parietal gliomas and Karnofsky performance score was 
determined in all patients after 2 weeks of surgery but 
contrary to our study, their sample size was very small 
(26 patients), maximum of their patients were in good 
preoperative functional status with KPS of 70 or above 
and superimposed on this, preoperative fMRI for iden-
tification of motor cortex was used in all patients. So 
the minor discrepancy observed in overall effective-
ness is most probably due to these positive factors in 
the study of XIE Jian et al. 
 Several studies have reported the effect of tumor 





 et al. found that patients with Glioblastoma 
that is located in eloquent areas had better prognosis 
but he could not define it as an independent factor. In 
our study, overall success rate was also clearly influ-
enced by tumor location. In case of frontal lobe glio-
mas, the procedure was most effective in improving 
Karnofsky performance score of 85.7% patients with 
these tumors, followed by parietal gliomas where it 
was successful in 75% of patients. The possible expla-
nation for this improvement may be because the mass 
effect near the motor strip area which is responsible 
for hemiparesis and low Karnofsky performance score 
is alleviated and functional status is improved. 
 
CONCLUSION 
Open surgery with tumor resection is a very effective 
procedure for the treatment of supra tentorial gliomas. 
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Effectiveness varies with age of the patient, location of 
the tumor and preoperative functional status of the 
patient. The procedure can be used safely. 
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